Exai: Exai Bio's RNA-based Liquid Biopsy Platform Delivers Promising Data on Detecting Breast Cancer at its Earliest Stages

Exai Bio is a California-based biotechnology company that develops oncRNA and AI-driven liquid biopsy technology for the treatment of cancer diagnosis.